Enhanced Factor VIII Heavy Chain for Gene Therapy of Hemophilia A
Open Access
- 1 March 2009
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 17 (3), 417-424
- https://doi.org/10.1038/mt.2008.292
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- The Enhancing Effects of the Light Chain on Heavy Chain Secretion in Split Delivery of Factor VIII GeneMolecular Therapy, 2007
- Existence of transient functional double-stranded DNA intermediates during recombinant AAV transductionProceedings of the National Academy of Sciences, 2007
- Self-Complementary Recombinant Adeno-Associated Viral Vectors: Packaging Capacity And The Role of Rep Proteins in Vector PurityHuman Gene Therapy, 2007
- Safe and efficient transduction of the liver after peripheral vein infusion of self-complementary AAV vector results in stable therapeutic expression of human FIX in nonhuman primatesBlood, 2006
- Efficient AAV1–AAV2 Hybrid Vector for Gene Therapy of HemophiliaHuman Gene Therapy, 2006
- Coagulation Factors with Improved Properties for Hemophilia Gene TherapySeminars in Thrombosis and Hemostasis, 2004
- Safety and efficacy of factor IX gene transfer to skeletal muscle in murine and canine hemophilia B models by adeno-associated viral vector serotype 1Blood, 2004
- Haemophilia prophylaxis in young patients–a long‐term follow‐upJournal of Internal Medicine, 1997
- Quantitative Analysis of the Packaging Capacity of Recombinant Adeno-Associated VirusHuman Gene Therapy, 1996
- Factor VIII C2 Domain Missense Mutations Exhibit Defective Trafficking of Biologically Functional ProteinsPublished by Elsevier ,1996